R. Flegel

发表

Pharmacokinetics of Cannabis Brownies: A Controlled Examination of Δ9-Tetrahydrocannabinol and Metabolites in Blood and Oral Fluid of Healthy Adult Males and Females.

G. Bigelow, E. Cone, R. Vandrey, 2020, Journal of analytical toxicology.

Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users.

G. Bigelow, E. Cone, R. Vandrey, 2020, Drug and alcohol dependence.

Urinary Pharmacokinetic Profile of Cannabinoids Following Administration of Vaporized and Oral Cannabidiol and Vaporized CBD-Dominant Cannabis.

G. Bigelow, E. Cone, R. Vandrey, 2019, Journal of analytical toxicology.

Urinary Excretion Profile of 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol (THCCOOH) Following Smoked and Vaporized Cannabis Administration in Infrequent Cannabis Users.

G. Bigelow, E. Cone, R. Vandrey, 2019, Journal of analytical toxicology.

Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid.

G. Bigelow, E. Cone, R. Vandrey, 2019, Journal of analytical toxicology.

Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults.

G. Bigelow, E. Cone, R. Vandrey, 2018, Journal of analytical toxicology.

Prescription opioids. III. Disposition of oxycodone in oral fluid and blood following controlled single-dose administration.

R. Heltsley, E. Cone, D. Black, 2015, Journal of analytical toxicology.

Prescription opioids. II. Metabolism and excretion patterns of hydrocodone in urine following controlled single-dose administration.

R. Heltsley, E. Cone, D. Black, 2013, Journal of analytical toxicology.

Prescription opioids. I. Metabolism and excretion patterns of oxycodone in urine following controlled single dose administration.

R. Heltsley, E. Cone, D. Black, 2013, Journal of analytical toxicology.

Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis.

G. Bigelow, E. Cone, R. Vandrey, 2020, Drug and alcohol dependence.

Non-smoker exposure to secondhand cannabis smoke II: Effect of room ventilation on the physiological, subjective, and behavioral/cognitive effects.

G. Bigelow, E. Cone, R. Vandrey, 2015, Drug and alcohol dependence.

Detection and quantification of codeine-6-glucuronide, hydromorphone-3-glucuronide, oxymorphone-3-glucuronide, morphine 3-glucuronide and morphine-6-glucuronide in human hair from opioid users by LC-MS-MS.

Nichole Bynum, K. Moore, Megan Grabenauer, 2018, Journal of analytical toxicology.

Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC), and their Metabolites Following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.

G. Bigelow, E. Cone, R. Vandrey, 2021, Journal of analytical toxicology.

An evaluation of selected oral fluid point-of-collection drug-testing devices.

J. Walsh, D. Crouch, R. Atkins, 2005, Journal of analytical toxicology.

Development of a Quantitative LC-MS-MS Assay for Codeine, Morphine, 6-Acetylmorphine, Hydrocodone, Hydromorphone, Oxycodone and Oxymorphone in Neat Oral Fluid.

Nichole Bynum, K. Moore, Megan Grabenauer, 2018, Journal of analytical toxicology.

Non-smoker exposure to secondhand cannabis smoke. I. Urine screening and confirmation results.

G. Bigelow, E. Cone, R. Vandrey, 2015, Journal of analytical toxicology.

Morphine and codeine in oral fluid after controlled poppy seed administration.

M. Concheiro, J. L. da Costa, R. Flegel, 2015, Drug testing and analysis.

Pharmacokinetic Profile of Δ9-tetrahydrocannabinol, Cannabidiol and Metabolites in Blood following Vaporization and Oral Ingestion of Cannabidiol Products.

G. Bigelow, E. Cone, R. Vandrey, 2022, Journal of analytical toxicology.

Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis

G. Bigelow, E. Cone, R. Vandrey, 2018, JAMA network open.

Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes.

G. Bigelow, E. Cone, R. Vandrey, 2017, Journal of analytical toxicology.

Prescription Opioids. IV: Disposition of Hydrocodone in Oral Fluid and Blood Following Single-Dose Administration.

R. Heltsley, E. Cone, D. Black, 2015, Journal of analytical toxicology.

Prescription Opioids. VI. Metabolism and Excretion of Hydromorphone in Urine Following Controlled Single-Dose Administration.

R. Heltsley, E. Cone, D. Black, 2016, Journal of analytical toxicology.

Drug and alcohol use among drivers admitted to a Level-1 trauma center.

Randolph Atkins, J Michael Walsh, Carnell Cooper, 2005, Accident; analysis and prevention.

Conversion of 7-Carboxy-Cannabidiol (7-COOH-CBD) to 11-nor-9-Carboxy-Tetrahydrocannabinol (THC-COOH) During Sample Preparation for GC-MS Analysis.

S. Vikingsson, R. Winecker, John M. Mitchell, 2021, Journal of analytical toxicology.

Epidemiology of Alcohol and Other Drug Use Among Motor Vehicle Crash Victims Admitted to a Trauma Center

Randolph Atkins, J Michael Walsh, Timothy J Kerns, 2004, Traffic injury prevention.

An evaluation of rapid point-of-collection oral fluid drug-testing devices.

J Michael Walsh, Leo Cangianelli, J. Walsh, 2003, Journal of analytical toxicology.

Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores

E. Cone, R. Vandrey, M. Elsohly, 2022, JAMA network open.

Nonsmoker Exposure to Secondhand Cannabis Smoke. III. Oral Fluid and Blood Drug Concentrations and Corresponding Subjective Effects.

G. Bigelow, E. Cone, R. Vandrey, 2015, Journal of analytical toxicology.

Assessment of the stability of DNA in specimens collected under conditions for drug testing-A pilot study.

Erin M Hall, Sarah Norsworthy, Megan D Shaffer, 2018, Forensic science international.

Methamphetamine and amphetamine isomer concentrations in human urine following controlled Vicks VapoInhaler administration.

M. Huestis, D. Gorelick, M. Concheiro, 2014, Journal of analytical toxicology.

Oral fluid with three modes of collection and plasma methamphetamine and amphetamine enantiomer concentrations after controlled intranasal l-methamphetamine administration.

M. Huestis, D. Gorelick, M. Concheiro, 2015, Drug testing and analysis.

Fentanyl as a marker of illicit drug use in morphine-positive urine specimens from workplace drug testing.

S. Vikingsson, Ruth E. Winecker, R. Flegel, 2024, Journal of Analytical Toxicology.

Update on Urine Adulterants and Synthetic Urine Samples to Subvert Urine Drug Testing.

Shannon T. Krauss, S. Vikingsson, Ruth E. Winecker, 2022, Journal of analytical toxicology.

Δ8-THC-COOH cross-reactivity with cannabinoid immunoassay kits and interference in chromatographic testing methods.

S. Vikingsson, Ruth E. Winecker, R. Flegel, 2023, Journal of analytical toxicology.

Prescription opioids. II. Metabolism and excretion patterns of hydrocodone in urine following controlled single-dose administration.

R. Heltsley, E. Cone, D. Black, 2013, Journal of analytical toxicology.

Prescription opioids. I. Metabolism and excretion patterns of oxycodone in urine following controlled single dose administration.

R. Heltsley, E. Cone, D. Black, 2013, Journal of analytical toxicology.